Literature DB >> 19490401

Nonenhancing brain metastases.

Sasan Karimi1, Eric Lis, Saba Gilani, Nicholas D'Ambrosio, Andrei Holodny.   

Abstract

The hallmark radiological finding in metastatic brain disease is multiple enhancing lesions. We report a case of metastatic lung cancer to the brain with a lack of contrast enhancement. We believe that this unusual finding is due to inadvertent "treatment" of the metastases with the antiangiogenic agent bevacizumab (Avastin).
Copyright © 2009 by the American Society of Neuroimaging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 19490401     DOI: 10.1111/j.1552-6569.2009.00389.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  5 in total

1.  Nonenhancing Leptomeningeal Metastases: Imaging Characteristics and Potential Causative Factors.

Authors:  Vaios Hatzoglou; Sasan Karimi; Eli L Diamond; Eric Lis; George Krol; Andrei I Holodny; Robert J Young
Journal:  Neurohospitalist       Date:  2016-01

2.  Cerebral Metastases of Lung Cancer Mimicking Multiple Ischaemic Lesions - A Case Report and Review of Literature.

Authors:  Anna Zacharzewska-Gondek; Hanna Maksymowicz; Małgorzata Szymczyk; Marek Sąsiadek; Joanna Bladowska
Journal:  Pol J Radiol       Date:  2017-09-15

Review 3.  FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review.

Authors:  Koichi Mitsuya; Yoko Nakasu; Shoichi Deguchi; Kensei Shirata; Koiku Asakura; Kazuaki Nakashima; Masahiro Endo; Toshiaki Takahashi; Nakamasa Hayashi
Journal:  Cancer Imaging       Date:  2020-11-23       Impact factor: 3.909

4.  Case Report: Atypical Solitary Brain Metastasis: The Role of MR Spectroscopy In Differential Diagnosis.

Authors:  Dusko Kozic; Nebojsa Lasica; Danica Grujicic; Savo Raicevic; Natasa Prvulovic Bunovic; Igor Nosek; Jasmina Boban
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

5.  Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumab.

Authors:  Naveed Wagle; Leia Nghiemphu; Albert Lai; Whitney Pope; Paul S Mischel; Timothy Cloughesy
Journal:  Pharmgenomics Pers Med       Date:  2010-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.